Human medicines European public assessment report (EPAR): Olanzapine Mylan, olanzapine, Date of authorisation: 06/10/2008, Revision: 20, Status: Authorised

Minutes of the PRAC meeting 4-7 March 2024

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 1

On-boarding of users to Substance, Product, Organisation and Referentials (SPOR) data services

Products Management Services - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe: Introduction - EU Implementation Guide

Agenda of the PRAC meeting 13-16 May 2024

Human medicines European public assessment report (EPAR): Ghryvelin (previously Macimorelin Aeterna Zentaris), macimorelin, Date of authorisation: 11/01/2019, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Anagrelide Viatris (previously Anagrelide Mylan), anagrelide, Date of authorisation: 15/02/2018, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Onglyza, saxagliptin, Date of authorisation: 30/09/2009, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Rasagiline Mylan, rasagiline, Date of authorisation: 04/04/2016, Revision: 8, Status: Authorised